Brimonidine in the treatment of glaucoma and ocular hypertension

LB Cantor - Therapeutics and clinical risk management, 2006 - Taylor & Francis
Treatment in glaucoma aims to lower intraocular pressure (IOP) to reduce the risk of
progression and vision loss. The alpha2-adrenergic receptor agonist brimonidine effectively …
被引用次数：127 相关文章
[PDF] psu.edu

[PDF][PDF] Brimonidine in the treatment of glaucoma and ocular hypertension

LB Cantor - Therapeutics and Clinical Risk Management, 2006 - Citeseer
Treatment in glaucoma aims to lower intraocular pressure (IOP) to reduce the risk of
progression and vision loss. The alpha2-adrenergic receptor agonist brimonidine effectively …

Brimonidine in the treatment of glaucoma and ocular hypertension

LB Cantor - Therapeutics and clinical risk management, 2006 - pubmed.ncbi.nlm.nih.gov
Treatment in glaucoma aims to lower intraocular pressure (IOP) to reduce the risk of
progression and vision loss. The alpha2-adrenergic receptor agonist brimonidine effectively …

Brimonidine in the treatment of glaucoma and ocular hypertension.

LB Cantor - Therapeutics and Clinical Risk Management, 2006 - europepmc.org
Abstract Treatment in glaucoma aims to lower intraocular pressure (IOP) to reduce the risk of
progression and vision loss. The alpha2-adrenergic receptor agonist brimonidine effectively …
[PDF] researchgate.net

[PDF][PDF] Brimonidine in the treatment of glaucoma and ocular hypertension

LB Cantor - Therapeutics and Clinical Risk Management, 2006 - researchgate.net
Treatment in glaucoma aims to lower intraocular pressure (IOP) to reduce the risk of
progression and vision loss. The alpha2-adrenergic receptor agonist brimonidine effectively …

Brimonidine in the treatment of glaucoma and ocular hypertension

LB Cantor - Therapeutics and Clinical Risk Management, 2006 - dovepress.com
Treatment in glaucoma aims to lower intraocular pressure (IOP) to reduce the risk of
progression and vision loss. The alpha2-adrenergic receptor agonist brimonidine effectively …
[HTML] nih.gov

[HTML][HTML] Brimonidine in the treatment of glaucoma and ocular hypertension

LB Cantor - Therapeutics and Clinical Risk Management, 2006 - ncbi.nlm.nih.gov
Abstract Treatment in glaucoma aims to lower intraocular pressure (IOP) to reduce the risk of
progression and vision loss. The alpha2-adrenergic receptor agonist brimonidine effectively …

Brimonidine in the treatment of glaucoma and ocular hypertension

LB Cantor - Therapeutics and Clinical Risk Management, 2006 - search.proquest.com
Abstract Treatment in glaucoma aims to lower intraocular pressure (IOP) to reduce the risk of
progression and vision loss. The alpha2-adrenergic receptor agonist brimonidine effectively …
[PDF] academia.edu

[PDF][PDF] Brimonidine in the treatment of glaucoma and ocular hypertension

LB Cantor - Therapeutics and Clinical Risk Management, 2006 - academia.edu
Treatment in glaucoma aims to lower intraocular pressure (IOP) to reduce the risk of
progression and vision loss. The alpha2-adrenergic receptor agonist brimonidine effectively …
[PDF] scienceopen.com

[PDF][PDF] Brimonidine in the treatment of glaucoma and ocular hypertension

LB Cantor - Therapeutics and Clinical Risk Management, 2006 - scienceopen.com
Treatment in glaucoma aims to lower intraocular pressure (IOP) to reduce the risk of
progression and vision loss. The alpha2-adrenergic receptor agonist brimonidine effectively …